Advances in technology have drastically reduced costs and implementation time for Whole Genome Sequencing (WGS). As of today the complete sequencing of the human genome has become more accessible and can even cost less than $1000 and using low-pass sequencing technologies even $150. Large use of WGS technologies at lower costs along with easy access to genomic data can significantly improve the productivity and efficiency of health care and social well-being (e.g, it can help researchers to identify the causes of multiple diseases and contribute to the development of new drugs) as well as improving the quality of life and increasing the possibility that people have a direct impact on their health. This paper proposes Genesy, an innovative blockchain platform which acts as an intermediary between the owner of the genomic data and its potential users (i.e., university research centers, private laboratories, hospitals, geneticists, etc.) to structure a new ecosystem that incentivize people to share their genomic data, leveraging the potentiality of blockchain technology to safekeep the users' exclusive property and access to their genomic data, allowing them to partecipate in the benefits and the advances of the genomic research.
|Published - Feb 2019